Cargando…
Nrf2 activator PB125® as a carnosic acid-based therapeutic agent against respiratory viral diseases, including COVID-19()
PB125® is a phytochemical composition providing potent Nrf2 activation as well as a number of direct actions that do not involve Nrf2. Nrf2 is a transcription actor that helps maintain metabolic balance by providing redox-sensitive expression of numerous genes controlling normal day-to-day metabolic...
Autores principales: | McCord, Joe M., Hybertson, Brooks M., Cota-Gomez, Adela, Gao, Bifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413148/ https://www.ncbi.nlm.nih.gov/pubmed/34058321 http://dx.doi.org/10.1016/j.freeradbiomed.2021.05.033 |
Ejemplares similares
-
Nrf2 Activator PB125® as a Potential Therapeutic Agent Against COVID-19
por: McCord, Joe M., et al.
Publicado: (2020) -
Nrf2 Activator PB125(®) as a Potential Therapeutic Agent against COVID-19
por: McCord, Joe M., et al.
Publicado: (2020) -
Phytochemical Combination PB125 Activates the Nrf2 Pathway and Induces Cellular Protection against Oxidative Injury
por: Hybertson, Brooks M., et al.
Publicado: (2019) -
Effects of the Phytochemical Combination PB123 on Nrf2 Activation, Gene Expression, and the Cholesterol Pathway in HepG2 Cells
por: Hybertson, Brooks M., et al.
Publicado: (2022) -
The Complex Genetic and Epigenetic Regulation of the Nrf2 Pathways: A Review
por: McCord, Joe M., et al.
Publicado: (2023)